Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyCaicun Zhou, Changxuan You, Changli Wang et al.|The Lancet Oncology|2011Cited by 4.1k
Characterizing Kidney and Liver Cysts in Monoallelic PKHD1 Individuals Identified in a Population-Based StudyDoaa E. Elbarougy, Peter C. Harris, Tabinda Jawaid et al.|Journal of the American Society of Nephrology|2024Cited by 0